Axxess Pharma Inc., a pharmaceutical company, engages in the marketing and distribution of various pharmaceutical products and diagnostic medical devices in Canada and internationally. The company distributes dermatological, therapeutic nutritional, pain management, and diagnostic products. Its principal product line includes Britical, Gravergol, Lactrase, Somnol, Triferexx, Urasal, Axspaz, Vivol, Hydraxx, Kemsol, Soropon, Amersol, Bactalase, Monurol, and Zynol, as well as skin care products. Axxess Pharma Inc. distributes its products through physicians, hospitals, government and defense institutions, and pharmacies. The company was founded in 1997 and is headquartered in Markham, Canada.